Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Learn how Us Market Index Funds Retirement 2024 provides core exposure to the U.S. market. Compare funds and refine your retirement allocation.
28,197 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
A Miami-based fintech has closed a $17 million Series A to speed fiat-to-stablecoin trades for businesses. The round ...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Super Micro Computer beat expectations on adjusted earnings and guided higher for Q4 revenue, while unveiling a nucle...
Apple launched the MacBook Neo at a budget price, signaling a potential breakthrough for Mac demand. This article bre...
IREN leaps on a landmark NVIDIA AI Cloud contract and a parallel equity option, signaling a strategic pivot from cryp...
Three EV peers face a common challenge: turn bold promises into durable profits. This guide compares Tesla, Rivian, a...
Eight senior executives have left Canoo in a fresh churn while the EV maker fights to meet long-running production ta...
Teresa Palacios Smith leads a broad push to embed inclusion into everyday operations at HomeServices of America, tur...
The CAAP 2026 earnings call offers more than quarterly results. This guide breaks down revenue drivers, margins, and ...
As Nvidia prepares to report, investors watch for more than headline numbers. This article explains Nvidia's billion ...
Stocks waver as the 10-Year Treasury yield breaks higher, pushing mortgage rates headed higher. Analysts warn borrowe...